A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions

Completed

Conditions studied: Basal Cell Carcinoma

In brief

The Dermacorder measures the electric field in the skin. Malignant skin lesions disrupt the skin's normal electric field and this abnormal electric field can be detected by the Dermacorder. Therefore the investigators are testing the hypothesis that the Dermacorder can provide useful data to guide in the diagnosis of skin disease.

Key facts

Study ID

NCT01014819

Run by

UCSF Benioff Children's Hospital Oakland

People needed

30

Starts

2009-10-01

Expected to finish

2011-07-01

Last updated by the study team

2011-08-03

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Study subjects must have had diagnosed at least one benign or malignant skin lesion;
• Subject is from 18-75 years of age, inclusive;
• Subject must sign and date all informed consent statements.

You may not qualify if…

• Subject is exhibiting signs of a bacterial or viral infection, including fever;
• Subject is unwilling to allow a biopsy of a malignant lesion for histological analysis.

Where it is running

• Childrens Hospital Oakland Research Institute — Oakland, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.